2,248
Views
2
CrossRef citations to date
0
Altmetric
Original Research

S100A4 promotes colon inflammation and colitis-associated colon tumorigenesis

ORCID Icon ORCID Icon, , , , , , & show all
Article: e1461301 | Received 08 Nov 2017, Accepted 30 Mar 2018, Published online: 11 Jun 2018

References

  • Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646–74. doi:10.1016/j.cell.2011.02.013. PMID:21376230.
  • Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;144:420:860–7. doi:10.1038/nature01322. PMID:12490959.
  • Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454:436–44. doi: 10.1038/nature07205. PMID:18650914.
  • Hernandez-Gea V, Toffanin S, Friedman SL, Llovet JM. Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma. Gastroenterology. 2013;144:512–27. doi:10.1053/j.gastro.2013.01.002. PMID:23313965.
  • Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66:7–30. doi:10.3322/caac.21332. PMID:26742998.
  • Xie J, Itzkowitz SH. Cancer in inflammatory bowel disease. World J. Gastroenterol. 2008;14:378–89. doi:10.3748/wjg.14.378. PMID:18200660.
  • Grivennikov SI. Inflammation and colorectal cancer: colitis-associated neoplasia. Semin Immunopathol. 2013;35:229–44. doi:10.1007/s00281-012-0352-6. PMCID:PMC3568220.
  • Herrinton LJ, Liu L, Levin TR, Allison JE, Lewis JD, Velayos F. Incidence and mortality of colorectal adenocarcinoma in persons with inflammatory bowel disease from 1998 to 2010. Gastroenterology. 2012;143:382–9. doi:10.1053/j.gastro.2012.04.054. PMID:22609382.
  • Rubin DC, Shaker A, Levin MS. Chronic intestinal inflammation: inflammatory bowel disease and colitis-associated colon cancer. Front Immunol. 2012;3:107. doi:10.3389/fimmu.2012.00107. PMID:22586430.
  • Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut. 2001;48:526–35. PMID:11247898.
  • Canavan C, Abrams KR, Mayberry J. Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn's disease. Aliment Pharmacol Ther. 2006;23:1097–104. doi:10.1111/j.1365-2036.2006.02854.x. PMID:16611269.
  • Klampfer L. Cytokines, inflammation and colon cancer. Curr. Cancer Drug Targets. 2011;11:451–64. PMID:21247378.
  • Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010;140:883–99. doi:10.1016/j.cell.2010.01.025. PMID:20303878.
  • Nicolas-Avila JA, Adrover JM, Hidalgo A. Neutrophils in homeostasis, immunity, and cancer. Immunity. 2017;46:15–28. doi:10.1016/j.immuni.2016.12.012. PMID:28099862.
  • Berraondo P, Minute L, Ajona D, Corrales L, Melero I, Pio R. Innate immune mediators in cancer: between defense and resistance. Immunol Rev. 2016;274:290–306. doi:10.1111/imr.12464. PMID:27782320.
  • Lewis CE, Harney AS, Pollard JW. The Multifaceted role of perivascular macrophages in tumors. Cancer cell. 2016;30:18–25. doi:10.1016/j.ccell.2016.05.017. PMID:27411586.
  • Boye K, Maelandsmo GM. S100A4 and metastasis: a small actor playing many roles. Am J Pathol. 2010;176:528–35. doi:10.2353/ajpath.2010.090526. PMID:20019188.
  • Bresnick AR, Weber DJ, Zimmer DB. S100 proteins in cancer. Nat Rev Cancer. 2015;15:96–109. doi:10.1038/nrc3893. PMID:25614008.
  • Zhang J, Chen L, Liu X, Kammertoens T, Blankenstein T, Qin Z. Fibroblast-specific protein 1/S100A4-positive cells prevent carcinoma through collagen production and encapsulation of carcinogens. Cancer Res. 2013;73:2770–81. doi:10.1158/0008-5472.CAN-12-3022. PMID:23539447.
  • Zhang J, Chen L, Xiao M, Wang C, Qin Z. FSP1+ fibroblasts promote skin carcinogenesis by maintaining MCP-1-mediated macrophage infiltration and chronic inflammation. Am J Pathol. 2011;178:382–90. doi:10.1016/j.ajpath.2010.11.017. PMID:21224075.
  • Chen L, Li J, Zhang J, Dai C, Liu X, Wang J, et al.. S100A4 promotes liver fibrosis via activation of hepatic stellate cells. J Hepatol. 2015;62:156–64. doi:10.1016/j.jhep.2014.07.035. PMID:25111176.
  • Strutz F, Okada H, Lo CW, Danoff T, Carone RL, Tomaszewski JE, et al.. Identification and characterization of a fibroblast marker: FSP1. J Cell Biol. 1995;130:393–405. PMID:7615639.
  • Osterreicher CH, Penz-Osterreicher M, Grivennikov SI, Guma M, Koltsova EK, Datz C, et al.. Fibroblast-specific protein 1 identifies an inflammatory subpopulation of macrophages in the liver. Proc Natl Acad Sci U S A. 2011;108:308–13. doi:10.1073/pnas.1017547108. PMID:21173249.
  • Mishra SK, Siddique HR, Saleem M. S100A4 calcium-binding protein is key player in tumor progression and metastasis: preclinical and clinical evidence. Cancer metastasis reviews. 2012;31:163–72. doi:10.1007/s10555-011-9338-4. PMID:22109080.
  • Kim EJ, Helfman DM. Characterization of the metastasis-associated protein, S100A4. roles of calcium binding and dimerization in cellular localization and interaction with myosin. J Biol Chem. 2003;278:30063–73. doi:10.1074/jbc.M304909200. PMID:12756252.
  • Liang J, Piao Y, Holmes L, Fuller GN, Henry V, Tiao N, et al.. Neutrophils promote the malignant glioma phenotype through S100A4. Clin Cancer Res. 2014;20:187–98. doi:10.1158/1078-0432.CCR-13-1279. PMID:24240114.
  • Fabris L, Cadamuro M, Moserle L, Dziura J, Cong X, Sambado L, et al.. Nuclear expression of S100A4 calcium-binding protein increases cholangiocarcinoma invasiveness and metastasization. Hepatology. 2011;54:890–9. doi:10.1002/hep.24466. PMID:21618579.
  • Schmidt-Hansen B, Ornas D, Grigorian M, Klingelhofer J, Tulchinsky E, Lukanidin E, et al.. Extracellular S100A4(mts1) stimulates invasive growth of mouse endothelial cells and modulates MMP-13 matrix metalloproteinase activity. Oncogene. 2004;23:5487–95. doi:10.1038/sj.onc.1207720. PMID:15122322.
  • Grum-Schwensen B, Klingelhofer J, Grigorian M, Almholt K, Nielsen BS, Lukanidin E, et al.. Lung metastasis fails in MMTV-PyMT oncomice lacking S100A4 due to a T-cell deficiency in primary tumors. Cancer Res. 2010;70:936–47. doi:10.1158/0008-5472.CAN-09-3220. PMID:20103644.
  • Hansen MT, Forst B, Cremers N, Quagliata L, Ambartsumian N, Grum-Schwensen B, et al.. A link between inflammation and metastasis: serum amyloid A1 and A3 induce metastasis, and are targets of metastasis-inducing S100A4. Oncogene. 2015;34:424–35. doi:10.1038/onc.2013.568. PMID:24469032.
  • Forst B, Hansen MT, Klingelhofer J, Moller HD, Nielsen GH, Grum-Schwensen B, et al.. Metastasis-inducing S100A4 and RANTES cooperate in promoting tumor progression in mice. PloS one. 2010;5:e10374. doi:10.1371/journal.pone.0010374. PMID:20442771.
  • O'Connell JT, Sugimoto H, Cooke VG, MacDonald BA, Mehta AI, LeBleu VS, et al.. VEGF-A and Tenascin-C produced by S100A4+ stromal cells are important for metastatic colonization. Proc Natl Acad Sci U S A. 2011;108:16002–7. doi:10.1073/pnas.1109493108. PMID:21911392.
  • Cho YG, Kim CJ, Nam SW, Yoon SH, Lee SH, Yoo NJ, et al.. Overexpression of S100A4 is closely associated with progression of colorectal cancer. World J Gastroenterol. 2005;11:4852–6. PMID:16097057.
  • Liu Y, Tang W, Wang J, Xie L, Li T, He Y, et al.. Clinicopathological and prognostic significance of S100A4 overexpression in colorectal cancer: a meta-analysis. Diagn Pathol. 2013;8:181. doi:10.1186/1746-1596-8-181. PMID:24188373.
  • Zhang J, Jiao Y, Hou S, Tian T, Yuan Q, Hao H, et al.. S100A4 contributes to colitis development by increasing the adherence of citrobacter rodentium in intestinal epithelial cells. Sci Rep. 2017;7:12099. doi:10.1038/s41598-017-12256-z. PMID:28935867.
  • Clapper ML, Cooper HS, Chang WC. Dextran sulfate sodium-induced colitis-associated neoplasia: a promising model for the development of chemopreventive interventions. Acta Pharmacol Sin. 2007;28:1450–9. doi:10.1111/j.1745-7254.2007.00695.x. PMID:17723178.
  • Flatmark K, Pedersen KB, Nesland JM, Rasmussen H, Aamodt G, Mikalsen SO, et al.. Nuclear localization of the metastasis-related protein S100A4 correlates with tumour stage in colorectal cancer. J. Pathol. 2003;200:589–95. doi:10.1002/path.1381. PMID:12898594.
  • Xue C, Plieth D, Venkov C, Xu C, Neilson EG. The gatekeeper effect of epithelial-mesenchymal transition regulates the frequency of breast cancer metastasis. Cancer Res. 2003;63:3386–94. PMID:12810675.
  • Iwano M, Fischer A, Okada H, Plieth D, Xue C, Danoff TM, et al.. Conditional abatement of tissue fibrosis using nucleoside analogs to selectively corrupt DNA replication in transgenic fibroblasts. Mol Ther. 2001;3:149–59. doi:10.1006/mthe.2000.0251. PMID:11237671.
  • Yammani RR, Carlson CS, Bresnick AR, Loeser RF. Increase in production of matrix metalloproteinase 13 by human articular chondrocytes due to stimulation with S100A4: role of the receptor for advanced glycation end products. Arthritis Rheum. 2006;54:2901–11. doi:10.1002/art.22042. PMID:16948116.
  • Dahlmann M, Okhrimenko A, Marcinkowski P, Osterland M, Herrmann P, Smith J, et al.. RAGE mediates S100A4-induced cell motility via MAPK/ERK and hypoxia signaling and is a prognostic biomarker for human colorectal cancer metastasis. Oncotarget. 2014;5:3220–33. doi:10.18632/oncotarget.1908. PMID:24952599.
  • Viennois E, Chen F, Merlin D. NF-kappaB pathway in colitis-associated cancers. Transl Gastrointest Cancer. 2013;2:21–9. doi:10.3978/j.issn.2224-4778.2012.11.01. PMID:23626930.
  • Greten FR, Eckmann L, Greten TF, Park JM, Li ZW, Egan LJ, et al.. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell. 2004;118:285–96. doi:10.1016/j.cell.2004.07.013. PMID:15294155.
  • Li ZH, Dulyaninova NG, House RP, Almo SC, Bresnick AR. S100A4 regulates macrophage chemotaxis. Mol Biol Cell. 2010;21:2598–610. doi:10.1091/mbc.E09-07-0609. PMID:20519440.
  • Cabezon T, Celis JE, Skibshoj I, Klingelhofer J, Grigorian M, Gromov P, et al.. Expression of S100A4 by a variety of cell types present in the tumor microenvironment of human breast cancer. Int. J. Cancer. 2007;121:1433–44. doi:10.1002/ijc.22850. PMID:17565747.
  • Kong P, Christia P, Saxena A, Su Y, Frangogiannis NG. Lack of specificity of fibroblast-specific protein 1 in cardiac remodeling and fibrosis. Am J Physiol Heart Circ Physiol. 2013;305:H1363–72. doi:10.1152/ajpheart.00395.2013. PMID:23997102.
  • Orre LM, Panizza E, Kaminskyy VO, Vernet E, Graslund T, Zhivotovsky B, et al.. S100A4 interacts with p53 in the nucleus and promotes p53 degradation. Oncogene. 2013;32:5531–40. doi:10.1038/onc.2013.213. PMID:23752197.
  • Zaki MH, Boyd KL, Vogel P, Kastan MB, Lamkanfi M, Kanneganti TD. The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis. Immunity. 2010;32:379–91. doi:10.1016/j.immuni.2010.03.003. PMID:20303296.
  • McEver RP, Baenziger NL, Majerus PW. Isolation and quantitation of the platelet membrane glycoprotein deficient in thrombasthenia using a monoclonal hybridoma antibody. J Clin Invest. 1980;66:1311–8. doi:10.1172/JCI109983. PMID:6449521.
  • Moolenbeek C, Ruitenberg EJ. The “Swiss roll”: a simple technique for histological studies of the rodent intestine. Lab Anim. 1981;15:57–9. PMID:7022018.